In vivo and in vitro pharmacology of SR 48,968, a non-peptide tachykinin NK2 receptor antagonist
- 1 March 1993
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 234 (1) , 83-90
- https://doi.org/10.1016/0014-2999(93)90709-q
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Tachykininergic transmission to the circular muscle of the guinea-pig ileum: evidence for the involvement of NK2 receptorsBritish Journal of Pharmacology, 1992
- The non‐peptide tachykinin antagonist, CP‐96,345, is a potent inhibitor of neurogenic inflammationBritish Journal of Pharmacology, 1992
- The role of peptides in the regulation of the micturition reflex: An updateGeneral Pharmacology: The Vascular System, 1991
- Tachykinin receptors in the airways and lung: What should we block?Pharmacological Research, 1990
- In vivo pharmacology of [βAla8]neurokinin A-(4-10), a selective NK-2 tachykinin receptor agonistEuropean Journal of Pharmacology, 1990
- Characterization of neurokinin receptors in various isolated organs by the use of selective agonistsLife Sciences, 1987
- Capsaicin‐induced inhibition of motility of the rat isolated vas deferens: do multiple neuropeptides mediate the visceromotor effects of capsaicin?Journal of Autonomic Pharmacology, 1987
- Multiple tachykinin binding sites in peripheral tissues and in brainEuropean Journal of Pharmacology, 1986
- Different receptors are involved in the endothelium-mediated relaxation and the smooth muscle contraction of the rabbit pulmonary artery in response to substance and related neurokininsEuropean Journal of Pharmacology, 1986
- Novel Pharmacology of Substance K-Binding Sites: a Third Type of Tachykinin ReceptorScience, 1984